NY, La. Eyed For MDL Consolidation Of Blood-Thinner Suits

By Nathan Hale (January 26, 2017, 7:54 PM EST) -- Bristol-Meyers Squibb Co. and Pfizer Inc. argued Thursday that dozens of suits alleging their blood-thinner Eliquis caused bleeding-related injuries should be centralized in the Southern District of New York, where both companies' headquarters are located, to improve efficiency and consistency as litigation progresses....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features such as